Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Urinary Tract Infection III: Diagnostic Studies and Interprofessional Care01:30

Urinary Tract Infection III: Diagnostic Studies and Interprofessional Care

333
A healthcare provider can diagnose a urinary tract infection (UTI) through several methods:Medical History and Symptoms: The provider will take a detailed medical history and ask about symptoms such as frequent urination, burning sensation during urination, and lower abdominal pain.Urinalysis: A clean-catch urine sample is collected in a sterile container and tested for the presence of bacteria, white blood cells (leukocytes), nitrites, blood, and protein. The presence of leukocytes and...
333
Appendicitis-II: Diagnostic Studies and Management01:29

Appendicitis-II: Diagnostic Studies and Management

601
Diagnosing and managing appendicitis requires a structured and comprehensive approach that spans from initial assessment to postoperative care. Here is an overview of the process:
Diagnosing Appendicitis
It requires a multifaceted approach, starting with a detailed physical examination to pinpoint the location and nature of the pain and identify any associated symptoms. Laboratory tests play a crucial role. A complete Blood Count (CBC) typically reveals leukocytosis (an increased number of...
601
Myasthenia Gravis: Diagnostic Tests01:15

Myasthenia Gravis: Diagnostic Tests

2.7K
Myasthenia gravis is an autoimmune condition affecting neuromuscular transmission, causing generalized weakness in skeletal muscles. Initial diagnoses rely on patients' signs, symptoms, and medical history. The challenge lies in distinguishing myasthenia from other muscular dystrophies. An important diagnostic feature is the significant improvement of symptoms after administering anticholinesterase inhibitors.
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
2.7K
Asthma-IV: Diagnostic and Management01:30

Asthma-IV: Diagnostic and Management

3.2K
The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
3.2K
Pericarditis II: Clinical Features and Diagnostic Tests01:19

Pericarditis II: Clinical Features and Diagnostic Tests

364
Pericarditis is distinguished by inflammation of the pericardium, the fibrous sac that encases the heart. It can be acute, lasting less than six weeks, or chronic, persisting for over three months. Understanding its clinical manifestations and diagnostic findings is crucial for timely and effective management.Clinical ManifestationsWhile pericarditis can be asymptomatic, it usually presents with characteristic symptoms such as:Chest Pain: The most characteristic symptom of pericarditis is chest...
364
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests01:27

Atherosclerosis II: Clinical Manifestations and Diagnostic Tests

579
Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...
579

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Safety and efficacy of faecal microbiota transplantation in Parkinson's disease.

NPJ Parkinson's disease·2026
Same author

From Aspergillus fumigatus pathogen surveillance to Aspergillus disease surveillance.

The Journal of hospital infection·2026
Same author

Characterization of the clade 4 non-toxigenic <i>C. difficile</i> isolate L-NTCD03 carrying the <i>cfr</i>(B) gene.

FEMS microbes·2026
Same author

Microbiota-derived short-chain fatty acids in hematopoietic stem cell transplantation: immunomodulation at the host-microbiota interface.

Frontiers in microbiology·2026
Same author

How to set up and manage a microbiome research facility.

Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases·2026
Same author

Genomic epidemiology of putative hypervirulent <i>Klebsiella pneumoniae</i> species complex in Dutch patients, January-December 2022.

Microbiology spectrum·2026
Same journal

Peptidomics in the Spotlight: Advanced Sample Treatment Techniques and Analytical Insights.

Advances in experimental medicine and biology·2026
Same journal

Methods for the Investigation of Protein-Ligands Interactions.

Advances in experimental medicine and biology·2026
Same journal

Sample Preparation Strategies for Microbial Cell Surface Proteomics: Integrating Shaving and Shotgun Approaches.

Advances in experimental medicine and biology·2026
Same journal

Proteomic Sample Preparation for the Petroleum Industry: A Biocorrosion Case Study.

Advances in experimental medicine and biology·2026
Same journal

Proteomic and Functional Comparison of Extracellular Vesicles from Wild-Type and Lyn-Deficient Stromal Cells.

Advances in experimental medicine and biology·2026
Same journal

Proteomic Analysis of Histone Sequence Variants and Post-translationally Modified Forms.

Advances in experimental medicine and biology·2026
See all related articles

Related Experiment Video

Updated: Feb 15, 2026

Development of a Larval Zebrafish Infection Model for Clostridioides difficile
09:13

Development of a Larval Zebrafish Infection Model for Clostridioides difficile

Published on: February 14, 2020

6.9K

Diagnostic Guidance for C. difficile Infections.

Monique J T Crobach1, Amoe Baktash2, Nikolas Duszenko2

  • 1Department of Medical Microbiology, Centre for Infectious Diseases, Leiden University Medical Centre, Leiden, The Netherlands. m.j.t.crobach@lumc.nl.

Advances in Experimental Medicine and Biology
|February 1, 2018
PubMed
Summary
This summary is machine-generated.

Diagnosing Clostridium difficile infection (CDI) is complex due to imperfect reference assays and rapid tests. Current guidelines advocate algorithmic testing, but variations in methods impact incidence rates.

Keywords:
Algorithmic testingClostridium difficileDiagnosticsTesting

More Related Videos

Fecal Microbiota Transplantation via Colonoscopy for Recurrent C. difficile Infection
07:06

Fecal Microbiota Transplantation via Colonoscopy for Recurrent C. difficile Infection

Published on: December 8, 2014

27.7K
A Protein Microarray Assay for Serological Determination of Antigen-specific Antibody Responses Following Clostridium difficile Infection
09:12

A Protein Microarray Assay for Serological Determination of Antigen-specific Antibody Responses Following Clostridium difficile Infection

Published on: June 15, 2018

10.5K

Related Experiment Videos

Last Updated: Feb 15, 2026

Development of a Larval Zebrafish Infection Model for Clostridioides difficile
09:13

Development of a Larval Zebrafish Infection Model for Clostridioides difficile

Published on: February 14, 2020

6.9K
Fecal Microbiota Transplantation via Colonoscopy for Recurrent C. difficile Infection
07:06

Fecal Microbiota Transplantation via Colonoscopy for Recurrent C. difficile Infection

Published on: December 8, 2014

27.7K
A Protein Microarray Assay for Serological Determination of Antigen-specific Antibody Responses Following Clostridium difficile Infection
09:12

A Protein Microarray Assay for Serological Determination of Antigen-specific Antibody Responses Following Clostridium difficile Infection

Published on: June 15, 2018

10.5K

Area of Science:

  • Microbiology
  • Infectious Diseases
  • Clinical Diagnostics

Background:

  • Clostridium difficile infection (CDI) diagnosis presents challenges, with ongoing debate regarding the gold standard reference assays: cell cytotoxicity neutralization assay (CCNA) and toxigenic culture (TC).
  • Rapid diagnostic assays, including enzyme immunoassays (EIAs) for glutamate dehydrogenase or toxins A/B, and nucleic acid amplification tests (NAATs), have limitations in sensitivity, specificity, or differentiating infection from asymptomatic colonization.
  • Variations in hospital testing protocols and sample selection criteria contribute to discrepancies in reported CDI incidence rates.

Purpose of the Study:

  • To review the diagnostic challenges and current methodologies for Clostridium difficile infection (CDI).
  • To evaluate the limitations of existing reference and rapid diagnostic assays for CDI.
  • To discuss the implications of diagnostic variability and explore emerging alternative testing strategies.

Main Methods:

  • Literature review of diagnostic assays for Clostridium difficile infection (CDI).
  • Analysis of limitations associated with cell cytotoxicity neutralization assay (CCNA), toxigenic culture (TC), enzyme immunoassays (EIAs), and nucleic acid amplification tests (NAATs).
  • Discussion of international guidelines advocating multi-step algorithmic testing and the impact of hospital-specific protocols.

Main Results:

  • Both CCNA and TC have limitations as gold standards, with TC potentially overestimating CDI rates by including asymptomatic carriers.
  • Rapid assays exhibit suboptimal sensitivity and/or specificity and cannot reliably distinguish between CDI and colonization.
  • Inconsistent application of diagnostic methods and sample selection criteria lead to variable CDI incidence rates.

Conclusions:

  • Current diagnostic methods for Clostridium difficile infection (CDI) remain imperfect, necessitating algorithmic approaches recommended by guidelines.
  • Despite recommendations, significant variation exists in diagnostic practices across healthcare settings, influencing epidemiological data.
  • While alternative strategies like faecal biomarkers and cytokine analysis show promise as adjunctive tools, they are not yet suitable replacements for conventional CDI testing.